Active Ingredient History
Enterococcus is a large genus of lactic acid bacteria of the phylum Bacillota. Enterococci are gram-positive cocci that often occur in pairs (diplococci) or short chains, and are difficult to distinguish from streptococci on physical characteristics alone. Two species are common commensal organisms in the intestines of humans: E. faecalis (90–95%) and E. faecium (5–10%). Rare clusters of infections occur with other species, including E. casseliflavus, E. gallinarum, and E. raffinosus. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acne Vulgaris (Phase 3)
Air Travel (Phase 2/Phase 3)
Basal Ganglia Diseases (Phase 4)
Brain Diseases (Phase 4)
Bronchopulmonary Dysplasia (Phase 3)
Carcinoma, Transitional Cell (Phase 4)
Central Nervous System Diseases (Phase 4)
Cerebral Ventriculitis (Phase 4)
Colitis, Ulcerative (Early Phase 1)
Crohn Disease (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Phase 4)
Gastrointestinal Microbiome (Phase 4)
Hyperoxaluria (Phase 1/Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 3)
Irritable Bowel Syndrome (Phase 4)
Movement Disorders (Phase 4)
Nephrolithiasis (Phase 1/Phase 2)
Nervous System Diseases (Phase 4)
Neurodegenerative Diseases (Phase 4)
Parkinson Disease (Phase 4)
Parkinsonian Disorders (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
